

New OZEM ETF offers investors exposure to weight-loss sector through top pharmaceutical companies Eli Lilly and Novo Nordisk, with potential for high growth but...
You can purchase shares of Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) through any online brokerage.
There are no as such competitors for Roundhill GLP-1 & Weight Loss ETF.
There is no analysis for Roundhill GLP-1 & Weight Loss ETF to provide a consensus price target.
The stock price for Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM) is $30.58 last updated November 3, 2026 at 8:04 AM EST.
There are no upcoming dividends for Roundhill GLP-1 & Weight Loss ETF.
Roundhill GLP-1 & Weight Loss ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Roundhill GLP-1 & Weight Loss ETF.
The Fund is an actively managed exchange-traded fund (ETF) that pursues its investment objective by seeking to provide exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help...